BenchSci

BenchSci is an AI platform transforming preclinical drug discovery and advancing the way scientists research and develop new medicines. Its agentic research environment, EMET, brings data, models, software, and scientific reasoning together in a single workspace, eliminating the need for scientists to navigate a fragmented research stack. At its core is an AI co-scientist supported by specialized agents for target identification, risk assessment, biomarker discovery, omics, and experimental design. These agents reason across BenchSci’s biological knowledge graph, 16 million closed-access papers, and hundreds of curated data sources, helping teams move confidently from disease hypothesis through target validation, safety assessment, and ADME/PK. Every output is traceable to its source, ensuring scientific rigor and transparency throughout the research process. EMET is model-agnostic, giving teams the flexibility to use the models best suited to their research. And because BenchSci never develops its own drugs, customers retain full ownership of their scientific discoveries and intellectual property.